Fast Track Initiative Closes approximately 130M USD Fund IV to Advance Healthcare Innovation October 22, 2025
FTI Portfolio Company RegCell’s Scientific Founder, Professor Shimon Sakaguchi, Awarded the 2025 Nobel Prize in Physiology or Medicine October 8, 2025
Neusignal Therapeutics Completes First-in-Human Study of NTX-083 in Healthy Volunteers September 3, 2025
Astellas Exercises Option to License Small Molecules Discovered Through Joint Research on Novel target with Alivexis September 2, 2025
SONIRE Receives FDA IDE Approval for Ultrasound-Guided HIFU Device in Unresectable Pancreatic Cancer August 19, 2025
FTI Makes Follow-On Investment in Global Vascular’s Series B to Advance First-in-Human Trials of BioStealth™ Stent August 1, 2025
AIRNA Raises USD 155 Million in Oversubscribed Series B Financing to Advance RNA Editing Therapies April 3, 2025
FTI Co-Leads USD 45.8 million Investment in RegCell to Accelerate Development of Treg therapy for Autoimmune Diseases March 22, 2025
FTI Announces Additional Investment in Neusignal Therapeutics to Develop Alzheimer’s Treatment February 17, 2025
SONIRE Therapeutics Receives FDA Breakthrough Device Designation for HIFU Pancreatic Cancer Treatment October 10, 2024
